Humana Inc (HUM) 168.20 $HUM 11.3% Return Seen to Date

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Humana Inc (HUM) 168.20 $HUM

11.3% Return Seen to Date on SmarTrend Humana Call (HUM)
Comtex SmarTrend(R) - Fri Oct 23, 10:04AM CDT
SmarTrend identified a Downtrend for Humana (NYSE:HUM) on June 23rd, 2015 at $189.40. In approximately 4 months, Humana has returned 11.25% as of today's recent price of $168.09.
HUM: 168.20 (+3.09)

Hurricane Hillary Shifts Left, Slamming More Stocks
at Investor's Business Daily - Thu Oct 22, 2:52PM CDT
Hillary Clinton has demonstrated a knack for striking fear in the hearts of investors -- first in pharmaceuticals, then in health insurance and now in cable TV. For example, the beginning of Valeant's (VRX) nearly 60% plunge in the last month can be...
BIIB: 276.99 (+0.16), VRX: 116.16 (+6.29), BMRN: 104.14 (+2.54), UNH: 115.92 (+2.11), CHTR: 183.00 (+4.62), AET: 105.89 (+2.53), HUM: 168.20 (+3.09), CI: 132.54 (+3.05), ANTM: 140.95 (+1.54), GILD: 107.99 (+0.39), TWC: 185.19 (+2.29), CMCSA: 61.98 (+0.28), REGN: 536.70 (+11.59)

Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and UnitedHealth Group
Zacks Equity Research - Zacks Investment Research - Thu Oct 22, 8:30AM CDT
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and UnitedHealth Group
CI: 132.54 (+3.05), ANTM: 140.95 (+1.54), UNH: 115.92 (+2.11), AET: 105.89 (+2.53), HUM: 168.20 (+3.09)

Doctors To Get Real-Time Prescription Drug Benefit Info To Cut Red Tape For Patients
Business Wire - Thu Oct 22, 6:00AM CDT
The era of getting a prescription from your doctor, only to learn later that the medication is not covered, is coming to an end. Health and wellness company Humana Inc. (NYSE: HUM) has announced a real-time prescription drug benefit service that gives doctors information about their Humana patients' drug coverage, pricing and network pharmacy options all while the patient is in the exam room.
HUM: 168.20 (+3.09)

Will Election 2016 Mean New Challenges for Health Insurers?
Zacks Equity Research - Zacks Investment Research - Wed Oct 21, 10:50AM CDT
Will Election 2016 Mean New Challenges for Health Insurers?
CI: 132.54 (+3.05), ANTM: 140.95 (+1.54), UNH: 115.92 (+2.11), AET: 105.89 (+2.53), HNT: 62.76 (+1.51), MOH: 63.74 (+0.88), HUM: 168.20 (+3.09)

Clinton questions plans for health insurers to merge
By KEN THOMAS - AP - Wed Oct 21, 10:02AM CDT
WASHINGTON (AP) — Hillary Rodham Clinton warned Wednesday that two major health insurers preparing multibillion dollar acquisitions could tip "the balance of power" too far away from consumers.
CI: 132.54 (+3.05), AET: 105.89 (+2.53), HUM: 168.20 (+3.09)

Humana and Guthrie Partner to Offer Value-Based Care in Twin Tiers Region
Business Wire - Wed Oct 21, 9:44AM CDT
Guthrie is teaming up with national health and well-being leader Humana Inc. (NYSE: HUM) on a value-based health care agreement designed to offer Humana's 4,000 Medicare Advantage members in north central Pennsylvania and south central New York an option for a more coordinated, more personalized health care experience.
HUM: 168.20 (+3.09)

Zacks Industry Outlook Highlights: UnitedHealth, Aetna, Cigna, Humana and Anthem
Zacks Equity Research - Zacks Investment Research - Wed Oct 21, 8:30AM CDT
Zacks Industry Outlook Highlights: UnitedHealth, Aetna, Cigna, Humana and Anthem
CI: 132.54 (+3.05), ANTM: 140.95 (+1.54), UNH: 115.92 (+2.11), AET: 105.89 (+2.53), HUM: 168.20 (+3.09)

Health Insurers Gain Under Obamacare
Zacks Equity Research - Zacks Investment Research - Tue Oct 20, 4:06PM CDT
Health Insurers Gain Under Obamacare
CI: 132.54 (+3.05), ANTM: 140.95 (+1.54), UNH: 115.92 (+2.11), AET: 105.89 (+2.53), HUM: 168.20 (+3.09)

Health insurers return to Illinois marketplace
By CARLA K. JOHNSON - AP - Tue Oct 20, 4:01PM CDT
CHICAGO (AP) — Prices are still a mystery, but Illinois consumers shopping for health insurance for 2016 will see familiar companies, newcomers and health plans with narrow networks when the marketplace opens in less than two weeks, according to information released Tuesday by the companies and state regulators.
AET: 105.89 (+2.53), HUM: 168.20 (+3.09)

Zacks Industry Outlook Highlights: CIGNA, Anthem, Humana, UnitedHealth Group and Centene
Zacks Equity Research - Zacks Investment Research - Tue Oct 20, 8:30AM CDT
Zacks Industry Outlook Highlights: CIGNA, Anthem, Humana, UnitedHealth Group and Centene
CNC: 57.25 (+1.72), CI: 132.54 (+3.05), ANTM: 140.95 (+1.54), UNH: 115.92 (+2.11), HUM: 168.20 (+3.09)

Oct. 20 Premarket Briefing: 10 Things You Should Know
at The Street - Tue Oct 20, 5:38AM CDT
U.S. stock futures are lower Tuesday ahead of a large number of major corporate earnings reports and housing data.
YHOO: 33.17 (+1.50), MU: 17.24 (+0.52), HOG: 48.20 (+0.09), IBM: 144.68 (+0.59), UTX: 100.62 (+0.83), CMG: 649.72 (-0.90), WDC: 69.34 (-0.62), VZ: 46.16 (+0.27), AET: 105.89 (+2.53), AAPL: 119.08 (+3.58), SNDK: 78.37 (+1.28), HUM: 168.20 (+3.09), UAL: 59.68 (+3.63)

Humana's stockholders approve merger with Aetna
M2 - Tue Oct 20, 4:35AM CDT
Humana Inc (NYSE: HUM) announced on Monday that during a special stockholder meeting held on 19 October 2015, its stockholders voted to approve the adoption of the merger agreement, dated 2 July 2015, providing for the acquisition of Humana by Aetna Inc.
AET: 105.89 (+2.53), HUM: 168.20 (+3.09)

Humana, Aetna shareholders approve $37 billion merger
By The Associated Press - AP - Mon Oct 19, 5:20PM CDT
Humana says shareholders at a special meeting overwhelming approved the company's takeover by fellow insurer Aetna.
AET: 105.89 (+2.53), HUM: 168.20 (+3.09)

Watch for Humana to Potentially Pullback After Gaining 1.34% Yesterday
Comtex SmarTrend(R) - Mon Oct 19, 4:21PM CDT
Humana (NYSE:HUM) traded in a range yesterday that spanned from a low of $183.90 to a high of $186.79. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $185.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HUM: 168.20 (+3.09)

After Yesterday's Rally of 1.34% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Oct 19, 4:21PM CDT
Humana (NYSE:HUM) traded in a range yesterday that spanned from a low of $183.90 to a high of $186.79. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $185.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HUM: 168.20 (+3.09)

Humana Stockholders Approve Pending Merger with Aetna
Business Wire - Mon Oct 19, 3:45PM CDT
Humana Inc. (NYSE: HUM) announced that during a special stockholder meeting held earlier today, its stockholders voted to approve the adoption of the previously announced merger agreement, dated as of July 2, 2015, providing for the acquisition of Humana by Aetna Inc.
AET: 105.89 (+2.53), HUM: 168.20 (+3.09)

Health Insurance Stock Outlook - Oct. 2015
Zacks Equity Research - Zacks Investment Research - Mon Oct 19, 1:29PM CDT
Health Insurance Stock Outlook - Oct. 2015
CI: 132.54 (+3.05), CNC: 57.25 (+1.72), ANTM: 140.95 (+1.54), UNH: 115.92 (+2.11), AET: 105.89 (+2.53), HNT: 62.76 (+1.51), HUM: 168.20 (+3.09)

UnitedHealth Group Is a Great Long-Term Investment, Despite Last Week's Earnings Report
at The Street - Mon Oct 19, 12:30PM CDT
UnitedHealth Group (UNH) stock got clobbered in the wake of its earnings release last week, but this stock is a long-term buy. Here's why.
JNJ: 100.31 (+0.78), MRK: 52.88 (+0.87), PFE: 34.05 (+0.72), UNH: 115.92 (+2.11), HUM: 168.20 (+3.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
UCB's Endowment Marks New Era in Medicine Evaluation

Updated Category News Views 60

Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...

Continue Reading
Vinitaly.USA 2026: Italian Wine Takes Manhattan

Updated Category News Views 11

A Two-Day Wine Extravaganza Hits New York If Italian wine was a stock, the Vinitaly.USA 2026 gathering in New York would be a rallying cry to double down. October 26-27 is set to be a whirl of handshakes and clinking glasses at Pier 36, all under the grand vision of beefing up Italy's hold on the U.S. wine market. As the compass points to growing opportunities, one can't...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 64

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

Updated Category News Views 24

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 160

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Egan-Jones Backs DGB's Push for Ethan Allen Shakeup

Updated Category News Views 81

Proxy Fight Brews Over Ethan Allen's Future Here we are, embroiled in another classic showdown in the corporate boardroom, and this time it's over at Ethan Allen—home of those plush couches and dining tables. Egan-Jones proxy services just threw its weight behind all five of DGB Investment's nominees for Ethan Allen’s board. This kind of tug-of-war isn't new, but each...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Advocacy for Hiring Disabled Kidney Patients Gains Steam

Updated Category News Views 254

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Continue Reading

Top 5 Most Recently Viewed Articles

Incredible Growth of Republic Services Over 15 Years Explored

Updated Category News Views 115

Investment Returns of Republic Services Explained Investing over a long period can significantly impact the value of your investment. One compelling example is Republic Services (RSG), which has demonstrated remarkable growth over the past 15 years. With an impressive annual return of 20.96%, Republic Services has outperformed many market benchmarks by a notable 8.71%...

Continue Reading
Experience Next-Level Haptics with bHaptics' Newest Devices

Updated Category News Views 446

Innovative Haptic Technology from bHaptics bHaptics has made a significant leap in the world of immersive experiences with the introduction of their latest products, the TactSuit Pro and TactSuit Air. This marks the company's first product launch in four years, showcasing their commitment to innovation in haptic technology. With a focus on delivering premium experiences...

Continue Reading
Investor Sentiment and Trends Surrounding S&P Global Stocks

Updated Category News Views 231

Understanding Current Investor Sentiment on S&P Global Recently, there has been a noticeable increase in short interest for S&P Global (SPGI). The percentage of short shares has climbed to 3.23%, reflecting a total of 2.94 million shares sold short. This figure comprises 0.96% of the total shares available for trading. Analysts believe that based on the current trading...

Continue Reading
Shell plc Enhances Share Buyback Strategy for Growth

Updated Category News Views 102

Shell plc Shares Buyback Announcement Transaction in Own Shares Shell plc recently announced the execution of share purchases as a vital component of its ongoing share buyback program. Details of Share Purchases The total number of shares purchased for cancellation on the mentioned date amounted to 266,073, 180,953, and 150,405 across various venues, showcasing the...

Continue Reading
Mexico Equity and Income Fund Declares Year-End Dividend Announcement

Updated Category News Views 153

Mexico Equity and Income Fund Dividend Declaration In a recent announcement that is sure to excite investors, the Mexico Equity and Income Fund, Inc. (NYSE: MXE) has declared a cash dividend of $0.2337 per share on its common stock. This dividend is a year-end offering that consists entirely of ordinary income, demonstrating the Fund's commitment to returning value to its...

Continue Reading